Today: 21 July 2026
IonQ, Inc.’s $1.8 Billion SkyWater Deal Hits FTC Delay as Quantum Stakes Rise
26 April 2026
2 mins read

IonQ, Inc.’s $1.8 Billion SkyWater Deal Hits FTC Delay as Quantum Stakes Rise

April 26, 2026, 15:06 EDT, College Park, Maryland.

IonQ Inc.’s bid to buy SkyWater Technology Inc. has hit another antitrust snag, as the Federal Trade Commission demanded more details from both sides, stretching out the review window, according to a securities filing. The FTC’s request, dated April 24, relates to the proposed deal that would fold SkyWater into IonQ.

The timing is key here: SkyWater sits at the heart of IonQ’s effort to take direct charge of its quantum hardware. Back in January, IonQ struck a deal to acquire the chipmaker for roughly $1.8 billion. The company argued the move would pull semiconductor manufacturing in-house and bolster its relationships with federal and defense clients.

A “Second Request” signals the FTC wants additional documents and data ahead of closing a deal. This move doesn’t outright block the transaction, but it does pause the merger timeline until the companies substantially comply, triggering another round of review. Federal Trade Commission

IonQ and SkyWater plan to reply swiftly and continue cooperating with the FTC. Both companies are still aiming to close the deal in either the second or third quarter of 2026, pending approval under the Hart-Scott-Rodino Act—the U.S. pre-merger law—and other required conditions.

SkyWater shareholders are set to get $15 in cash plus $20 in IonQ stock per share, according to terms rolled out back in January. Post-acquisition, SkyWater becomes a wholly owned division of IonQ, with CEO Thomas Sonderman answering directly to IonQ Chairman and CEO Niccolo de Masi.

De Masi said buying SkyWater would let IonQ “secure its fully scalable supply chain domestically.” Sonderman pointed to the deal’s potential to “accelerate multiple engineering pathways” for next-generation quantum chips. SkyWater Technology

There’s a risk here: if the review drags on, the economics of the deal could shift. IonQ and SkyWater laid that out in their proxy, cautioning that regulatory pushback—anything from imposed conditions to outright delays or a failed sign-off—might stall or even kill the transaction before it closes.

IonQ ended Friday at $42.69, sliding 2.19% from its prior finish. Roughly 20.7 million shares changed hands during the session. The company’s most recent market cap checked in at $12.57 billion.

The FTC delay drops as investors juggle a flurry of quantum names. This week, Northland Capital Markets’ Nehal Chokshi started coverage on IonQ with an Outperform and set a $55 price target. D-Wave Quantum and Rigetti Computing, though, only picked up Market Perform calls. Xanadu Quantum Technologies landed an Outperform rating as well.

The industry isn’t there yet on quantum advantage — that moment when quantum hardware outpaces traditional computers in practical tasks is still on the horizon. Chokshi called photonic, or light-driven, systems “best positioned” thanks to their interconnects, highlighting how the market is still testing out different approaches and hasn’t landed on a clear leader. Investing.com

IonQ’s filing stops short of mentioning any lawsuit or formal remedy request from the FTC. Instead, what stands out is how the process shifts from IonQ’s own public roadmap to following the regulator’s schedule.

The SkyWater deal still makes sense strategically, but IonQ no longer fully controls how or when it gets done—the timeline has turned sluggish, and that’s now the main overhang.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Cadiz, ArriVent BioPharma, Acco Brands join Zacks Strong Sell list for July 21st
    July 21, 2026, 6:12 AM EDT. Cadiz (CDZI), ArriVent BioPharma (AVBP), and Acco Brands (ACCO) were added to the Zacks Rank #5 (Strong Sell) List. Cadiz's earnings estimate tumbled 40%, while ArriVent BioPharma slipped 7.3% and Acco Brands dropped 5.1% in consensus earnings over the past 60 days. These moves mark a significant slide in expected earnings for July 21st.
Skillz Stock’s $420 Million Papaya Verdict Rally Faces a Fast Reality Check
Previous Story

Skillz Stock’s $420 Million Papaya Verdict Rally Faces a Fast Reality Check

Dow Jones Today: Oil Spike, Fed Week and Big Tech Earnings Put Rally on Edge
Next Story

Dow Jones Today: Oil Spike, Fed Week and Big Tech Earnings Put Rally on Edge

Go toTop